ISB
The method, which uses a metabolic marker called hexokinase-2, could be developed to predict cancer patient prognosis and determine progression-free survival.
Merck, ISB Collaborating on COVID-19 Drug, Vaccine Target Discovery
Backed by BARDA, Merck and Institute for Systems Biology are studying multiomic
Researchers' picks range from emerging tools like deep learning to fundamental issues like false discovery rates and infrastructure for mass spec data sharing.
Highlights included mass spec-focused developments like data-independent acquisition and ion mobility along with platforms including Thermo Fisher's Q Exactive.
Arivale Shuts Down Personalized Wellness Business
The company published a letter on its website explaining that the genetic and other analyses involved in its services were too costly for customers to support.